Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women

NCT ID: NCT05058326

Last Updated: 2022-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

41 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-20

Study Completion Date

2021-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to stablish a correlation between fecal incontinence severity scales (Wexner \& St. Mark's) and manometric values obtained using the Anopress® portable manometry and values obtained using endoanal ultrasound in women with fecal incontinence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Anopress® portable anal manometry will be used to measure the pressures of the anal canal in different phases: rest, squeeze, strain and endurance.

All female patients referred with the diagnosis of fecal incontinence giving written informed consent will undergo a endoanal portable manometry at our outpatients clinics. They will be asked to fill out the severity questionaries (Sant Mark's and Wexner). All data will be collected for analysis.

An endoanal ultrasound will be performed in all patients to assess the sphincter integrity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fecal Incontinence Anal; Sphincter, Incontinence Incontinence, Urge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TEST GROUP

Women with fecal incontinence referred to outpatients clinic.

Portable endoanal manometry

Intervention Type DIAGNOSTIC_TEST

Endoanal manometry values will be obtained using de Anopress® device. Fecal incontinence severity questionaries will be filled and collected.

Endoanal ultrasound

Intervention Type DIAGNOSTIC_TEST

To assess the integrity of the anal canal.

Incontinence severity scale questionaires

Intervention Type OTHER

Wexner and St. Mark's scales.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Portable endoanal manometry

Endoanal manometry values will be obtained using de Anopress® device. Fecal incontinence severity questionaries will be filled and collected.

Intervention Type DIAGNOSTIC_TEST

Endoanal ultrasound

To assess the integrity of the anal canal.

Intervention Type DIAGNOSTIC_TEST

Incontinence severity scale questionaires

Wexner and St. Mark's scales.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with the clinical diagnosis of fecal incontinence
* Age ≥ 18 years.
* Informed consent signed by the patient and the researcher.

Exclusion Criteria

* Patients with psychiatric illnesses, addictions or any disorder that prevents understanding of the study.
* Inability to read or understand the questionnaires.
* Inability to read or understand any of the informed consent languages (Catalan, Spanish).
* Any patient who, due to his medical characteristics, presents a high individual risk when being included and completing the study.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitari Dr. Josep Trueta de Girona

Girona, Catalonia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

052020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.